Home > Boards > Free Zone > Health and Sciences > Biotech Values

Start-up, Bonti seeks short-acting botulinum toxin—(but not for

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 722
Posts 109,328
Boards Moderated 13
Alias Born 09/05/02
160x600 placeholder
DewDiligence Member Level  Wednesday, 01/24/18 01:20:25 PM
Re: DewDiligence post# 216656
Post # of 226484 
Start-up, Bonti seeks short-acting botulinum toxin—(but not for the reason recently cited by AGN executive):

https://www.wsj.com/articles/former-botox-bosses-raise-15-5-million-for-biotech-startup-bonti-1516745274
Quote:
Bonti says its botulinum neurotoxin takes action within 24 hours, and is effective for three to four weeks. This profile makes it suitable for uses such as treating postsurgical and nonsurgical musculoskeletal pain, according to the company, which is based in Newport Beach, Calif.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist